These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2509400)

  • 1. TRH treatment in cerebellar ataxia following a lightning stroke.
    Morocutti C; Spadaro M; Amabile G
    Ital J Neurol Sci; 1989 Oct; 10(5):531. PubMed ID: 2509400
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of Cockayne syndrome with cerebellar ataxia improved after TRH therapy (author's transl)].
    Naito H
    Horumon To Rinsho; 1982 Mar; 30(3):261-6. PubMed ID: 6807582
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of thyrotropin-releasing hormone in the treatment of cerebellar ataxia.
    Takeuchi Y; Fujiwara K; Ishimura K; Shimada Y; Ochi M; Yoshioka H; Sawada T
    Pediatr Neurol; 1989; 5(2):107-10. PubMed ID: 2469426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic effects of thyrotropin-releasing hormone (TRH) on stabilogram in spinocerebellar degenerations.
    Yoshida M; Nakanishi T; Komatsu Y
    Tohoku J Exp Med; 1986 Mar; 148(3):327-31. PubMed ID: 3085285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations.
    Sobue I; Takayanagi T; Nakanishi T; Tsubaki T; Uono M; Kinoshita M; Igata A; Miyazaki M; Yoshida M; Ando K
    J Neurol Sci; 1983 Oct; 61(2):235-48. PubMed ID: 6417282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor disabilities and effects of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration.
    Kimura I; Ohtomo H; Kogure K
    Tohoku J Exp Med; 1983 Apr; 139(4):331-7. PubMed ID: 6408760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinocerebellar degenerations--clinical aspects and new treatment of ataxia.
    Sobue I
    Jpn J Med; 1985 Feb; 24(1):62-7. PubMed ID: 3923240
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic trial in a family with late cerebellar atrophy].
    Gracia Naya M; Pina Latorre MA
    Neurologia; 1991 May; 6(5):188-9. PubMed ID: 1908256
    [No Abstract]   [Full Text] [Related]  

  • 9. [Spinocerebellar degenerations].
    Sobue I
    Nihon Naika Gakkai Zasshi; 1984 Oct; 73(10):1415-31. PubMed ID: 6440937
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of DN-1417, a synthetic thyrotropin-releasing hormone analogue, on [3H]GABA binding in the cerebellum of ataxic rats.
    Tatsuoka Y; Kato Y; Imura H
    Neurosci Lett; 1985 Jan; 53(1):63-8. PubMed ID: 2986054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ataxia in rolling mouse Nagoya and the norepinephrine system--a psychopharmacological study].
    Matsui K; Toyoshima E; Mano U; Ando K
    Yakubutsu Seishin Kodo; 1982 Dec; 2(2):77-80. PubMed ID: 6821292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effects of thyrotropin releasing hormone (TRH) therapy on regional cerebral blood flow in the cerebellar variant of multiple system atrophy using 3DSRT.
    Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T
    J Neuroimaging; 2011 Apr; 21(2):132-7. PubMed ID: 19674246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRH receptor agonists ameliorate 3-acetylpyridine-induced ataxia through NMDA receptors in rats.
    Kinoshita K; Watanabe Y; Yamamura M; Matsuoka Y
    Eur J Pharmacol; 1998 Feb; 343(2-3):129-33. PubMed ID: 9570459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [NEUROPSYCHIATRIC PHENOMENA FOLLOWING LIGHTNING-STROKE ACCIDENTS].
    IRANYI K; IRANYI J; OROVECZ B; SOMOGYI E
    Psychiatr Neurol Med Psychol (Leipz); 1964 Aug; 16():310-5. PubMed ID: 14301241
    [No Abstract]   [Full Text] [Related]  

  • 15. Alterations in local cerebral glucose metabolism and endogenous thyrotropin-releasing hormone levels in rolling mouse Nagoya and effect of thyrotropin-releasing hormone tartrate.
    Nakayama T; Nagai Y
    Jpn J Pharmacol; 1996 Nov; 72(3):241-6. PubMed ID: 8957685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT.
    Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T; Arakawa R
    J Neurol Sci; 2009 Jun; 281(1-2):93-8. PubMed ID: 19286195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Symptomatic analysis of cerebellar ataxia].
    Ando N
    No To Shinkei; 1995 Jan; 47(1):15-21. PubMed ID: 7669397
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effects of thyrotropin releasing hormone (TRH) on motor execution and motor adaptation process in patients with spinocerebellar degeneration.
    Shimizu T; Tsutsumi R; Shimizu K; Tominaga N; Nagai M; Ugawa Y; Nishiyama K; Hanajima R
    J Neurol Sci; 2020 Aug; 415():116927. PubMed ID: 32474221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatments of cerebellar ataxia.
    Ogawa M
    Cerebellum; 2004; 3(2):107-11. PubMed ID: 15233578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and electrocardiographic observations on 6 men following lightning strokes].
    ROESENER G
    Elektromed Biomed Tech; 1962 Mar; 7():24-34. PubMed ID: 15445958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.